Published in Rev Bras Ter Intensiva on March 01, 2013
Use of biomarkers in pediatric sepsis: literature review. Rev Bras Ter Intensiva (2017) 0.75
Sepsis biomarkers: a review. Crit Care (2010) 4.76
Measures, markers, and mediators: toward a staging system for clinical sepsis. A report of the Fifth Toronto Sepsis Roundtable, Toronto, Ontario, Canada, October 25-26, 2000. Crit Care Med (2003) 2.01
Multicenter, randomized, controlled trials evaluating mortality in intensive care: doomed to fail? Crit Care Med (2008) 2.00
Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov (2003) 1.92
C-reactive protein: a valuable marker of sepsis. Intensive Care Med (2002) 1.82
C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study. Crit Care (2011) 1.31
C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Crit Care Med (2008) 1.25
C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Crit Care (2011) 1.10
Serum markers in community-acquired pneumonia and ventilator-associated pneumonia. Curr Opin Infect Dis (2008) 1.01
Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study. J Crit Care (2011) 1.01
Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study. BMC Infect Dis (2007) 0.86
Open versus laparoscopic treatment for pan-peritonitis secondary to perforated appendicitis in children: a prospective analysis. J Laparoendosc Adv Surg Tech A (2010) 0.84
Novel biomarkers in severe community-acquired pneumonia. Rev Bras Ter Intensiva (2011) 0.84
Serum C-reactive protein concentrations in early abdominal and pulmonary sepsis. Rev Bras Ter Intensiva (2013) 0.80
Biomarkers as end points in clinical trials of severe sepsis: a garden of forking paths. Crit Care Med (2010) 0.79
Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams. Crit Care (2011) 1.48
Early sedation and clinical outcomes of mechanically ventilated patients: a prospective multicenter cohort study. Crit Care (2014) 1.44
The validity and reliability of the Portuguese versions of three tools used to diagnose delirium in critically ill patients. Clinics (Sao Paulo) (2011) 1.33
Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Crit Care (2007) 1.19
Trials of biomarker-guided antimicrobial therapy in sepsis: improvements in trial design require better control groups. Crit Care Med (2014) 1.06
The predisposition, infection, response and organ failure (Piro) sepsis classification system: results of hospital mortality using a novel concept and methodological approach. PLoS One (2013) 1.04
The role of corticosteroids in severe community-acquired pneumonia: a systematic review. Crit Care (2008) 1.03
Impact of systemic corticosteroids on the clinical course and outcomes of patients with severe community-acquired pneumonia: a cohort study. J Crit Care (2011) 1.01
Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Crit Care (2012) 1.00
Should C-reactive protein concentration at ICU discharge be used as a prognostic marker? BMC Anesthesiol (2010) 0.95
Severe acute tumor lysis syndrome in patients with germ-cell tumors. Indian J Urol (2008) 0.90
Incidence and diagnosis of ventilator-associated tracheobronchitis in the intensive care unit: an international online survey. Crit Care (2014) 0.89
Diagnostic accuracy of C-reactive protein and procalcitonin in the early detection of infection after elective colorectal surgery - a pilot study. BMC Infect Dis (2014) 0.86
Assessment of risk factors for in-hospital mortality after intensive care unit discharge. Biomarkers (2012) 0.85
Perceptions and practices regarding delirium, sedation and analgesia in critically ill patients: a narrative review. Rev Bras Ter Intensiva (2013) 0.85
Novel biomarkers in severe community-acquired pneumonia. Rev Bras Ter Intensiva (2011) 0.84
The neuroprotective role of therapeutic hypothermia after cardiac arrest. Rev Bras Ter Intensiva (2011) 0.80
Continuous infusion of piperacillin/tazobactam in septic critically ill patients--a multicenter propensity matched analysis. PLoS One (2012) 0.80
Corticosteroids for H1N1 associated acute lung injury: is it just wishful thinking? Intensive Care Med (2010) 0.79
Biomarkers as end points in clinical trials of severe sepsis: a garden of forking paths. Crit Care Med (2010) 0.79
[Severe imported malaria in critical care patients]. Acta Med Port (2012) 0.77
Successful use of parenteral ivermectin in an immunosuppressed patient with disseminated strongyloidiasis and septic shock. Intensive Care Med (2005) 0.77
Corticosteroids in Severe Sepsis and Septic Shock: A Concise Review. Shock (2017) 0.76
Corticosteroids in critically ill patients: A long and winding road. Arch Surg (2006) 0.75
Echinocandins--first line in invasive candidiasis: how strong is this 'strong' evidence? Crit Care (2011) 0.75
Authors’ response. Crit Care (2013) 0.75
Corticosteroids in severe community-acquired pneumonia: the path we choose depends on where we want to get. Crit Care (2011) 0.75
Hydrocortisone and treatment of multiple trauma. JAMA (2011) 0.75
Prevention of delirium in critically ill patients: a new beginning? Rev Bras Ter Intensiva (2012) 0.75
Corticosteroids in sepsis: pathophysiological rationale and the selection of patients. Endocr Metab Immune Disord Drug Targets (2010) 0.75
The current status of biomarkers for the diagnosis of nosocomial pneumonias. Curr Opin Crit Care (2017) 0.75
Infection prevalence and outcomes in Brazilians ICUs: another brick in the wall... Rev Bras Ter Intensiva (2012) 0.75